MTOR and ovarian carcinoma: Deregulation of PI3K/PTEN/Akt/mTOR signaling was observed in solid tumors and in pancreatic and ovarian cancer and plays a crucial role in drug resistance [42,44], indicating mTOR as an attractive drug target.